176 related articles for article (PubMed ID: 25987053)
1. May the neutrophil/lymphocyte ratio be a predictor in the differentiation of different thyroid disorders?
Kocer D; Karakukcu C; Karaman H; Gokay F; Bayram F
Asian Pac J Cancer Prev; 2015; 16(9):3875-9. PubMed ID: 25987053
[TBL] [Abstract][Full Text] [Related]
2. Delta Neutrophil Index and Neutrophil-to-Lymphocyte Ratio in the Differentiation of Thyroid Malignancy and Nodular Goiter.
Bozan MB; Yazar FM; Kale İT; Yüzbaşıoğlu MF; Boran ÖF; Azak Bozan A
World J Surg; 2021 Feb; 45(2):507-514. PubMed ID: 33067685
[TBL] [Abstract][Full Text] [Related]
3. Systemic immune-inflammation index: A new marker in differentiation of different thyroid diseases.
Vural S; Muhtaroğlu A; Güngör M
Medicine (Baltimore); 2023 Aug; 102(31):e34596. PubMed ID: 37543770
[TBL] [Abstract][Full Text] [Related]
4. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?
Lang BH; Ng CP; Au KB; Wong KP; Wong KK; Wan KY
World J Surg; 2014 Oct; 38(10):2605-12. PubMed ID: 24809487
[TBL] [Abstract][Full Text] [Related]
5. Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer.
Yaylaci S; Tosun O; Sahin O; Genc AB; Aydin E; Demiral G; Karahalil F; Olt S; Ergenc H; Varim C
Asian Pac J Cancer Prev; 2016; 17(4):2321-3. PubMed ID: 27221938
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to Lymphocyte Ratio is Useful in Differentiation of Malign and Benign Thyroid Nodules.
Sit M; Aktas G; Erkol H; Yaman S; Keyif F; Savli H
P R Health Sci J; 2019 Mar; 38(1):60-63. PubMed ID: 30924917
[TBL] [Abstract][Full Text] [Related]
7. Comparison of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with thyroiditis and papillary tumors.
Ari A; Gunver F
J Int Med Res; 2019 May; 47(5):2077-2083. PubMed ID: 30909773
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases.
Fiore E; Rago T; Scutari M; Ugolini C; Proietti A; Di Coscio G; Provenzale MA; Berti P; Grasso L; Mariotti S; Pinchera A; Vitti P
J Endocrinol Invest; 2009 Apr; 32(4):344-51. PubMed ID: 19636204
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
[TBL] [Abstract][Full Text] [Related]
10. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-Lymphocyte Ratio Is Associated With the Proportion of Poorly Differentiated Components in Papillary Thyroid Carcinoma.
Oba T; Maeno K; Kiyosawa N; Morikawa H; Amitani M; Chino T; Shimizu T; Ono M; Ito T; Kanai T; Uehara T; Ito KI
J Surg Res; 2023 Jul; 287():47-54. PubMed ID: 36868123
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
13. Papillary Thyroid Cancer and Coexisting Autoimmune Thyroiditis.
Veit F; Graf D; Momberger S; Helmich-Kapp B; Ruschenburg I; Peters A; Kussmann J; Saeger W; Schmidt KW; Toetsch M; Nestler K; Mann K
Horm Metab Res; 2017 Nov; 49(11):869-872. PubMed ID: 29136676
[TBL] [Abstract][Full Text] [Related]
14. The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis.
Gulcelik NE; Akin S; Aydin K; Aydin Mericoz C; Guler Tezel YG; Usman A
Minerva Endocrinol (Torino); 2023 Dec; 48(4):379-386. PubMed ID: 35775885
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas.
Kim JY; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC; Ha WS; Choi SK; Jung EJ
Endocrine; 2014 Aug; 46(3):526-31. PubMed ID: 24272600
[TBL] [Abstract][Full Text] [Related]
16. The Neutrophil-to-Lymphocyte Ratio Correlates with Age in Patients with Papillary Thyroid Carcinoma.
Liu J; Du J; Fan J; Liu K; Zhang B; Wang S; Wang W; Wang Z; Cai Y; Li C; Yu T; Zhu G; Chen J; Li C
ORL J Otorhinolaryngol Relat Spec; 2015; 77(2):109-16. PubMed ID: 25896501
[TBL] [Abstract][Full Text] [Related]
17. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma.
Loh KC; Greenspan FS; Dong F; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1999 Feb; 84(2):458-63. PubMed ID: 10022401
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the correlation of neutrophil/lymphocyte ratio with prognostic classification systems in papillary thyroid carcinoma patients.
Yildiz EO; Işcen K; Kaya F; Güney OA; Ulukent SC
Medicine (Baltimore); 2024 Feb; 103(5):e37210. PubMed ID: 38306518
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
[TBL] [Abstract][Full Text] [Related]
20. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
